Pulished Date August, 2019
ID: 532
Share on
Share on

Preclinical In-vivo Imaging Market Analysis - By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), By Region - Global Industry Analysis on Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: August, 2019
ID: 532
Pages: 175

Preclinical In-vivo Imaging Market Size & Growth (2019 - 2024)

The size of the Global Preclinical In-Vivo Imaging market has been estimated at USD 714.17 Million in 2019 and is projected to reach USD 944.95 Million by 2024, at a CAGR of 5.76% during the forecast period from 2019 to 2024.  

Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. Imaging modalities that are non-invasive and in-vivo is important to study animal models longitudinally. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are usually used for molecular visualizations. The preclinical in-vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and change in government funding and support for research studies across the globe over the past decade.

Globally, factors such as technological advancements in molecular imaging modalities, growing acceptance of preclinical imaging as a legitimate drug development tool, are fuelling the demand for preclinical imaging systems and reagents.

Declining NIH budgets for medical science research studies and high implementation cost of sophisticated preclinical imaging systems are restricting the growth of the global preclinical imaging market.

Recent Happenings in the Global Preclinical In-Vivo Imaging Industry:

  • Aspect Imaging, one of the market players in designing and developing compact magnetic resonance systems for preclinical, medical and industrial applications, unveiled in September 2017 that Quantum Analytics will be its exclusive U.S. distributor for the Industrial product portfolio of Aspect Imaging.
  • In mid-2019, Kawasaki Medical University, the research center for state-of-the-art medical science and services in Yokohama, acquired an ultra-high-resolution E-Class U-SPECT6/CT system for preclinical imaging and installed the first MILabs E-Class U-SPECT6/CT system in Japan.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Modality, Reagent & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging and FUJIFILM VisualSonics, Inc.

 

This research report on the Global Preclinical In-vivo Imaging Market has been segmented and sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.

Preclinical In-vivo Imaging Market Analysis - By Modality                

  • Optical imaging      
    • Bioluminescence/fluorescence imaging systems
    • Standalone fluorescence imaging systems
    • Optical + X-ray/optical + CT imaging systems
  • Nuclear imaging    
    • Micro-PET systems (standalone PET, PET/CT, and PET/MRI)
    • Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)
    • Tri-modality (PET/SPECT/CT) imaging systems
  • Micro-MRI               
  • Micro-CT  
  • Micro-ultrasound 
  • Photoacoustic        
  • Magnetic particle imaging systems         

On the basis of modality, the segment of Micro-ultrasound is anticipated to grow with the fastest CAGR and would be a significant contributor to the global market for preclinical In-vivo imaging. Micro-ultrasound is a smaller ultrasound version with a broader variety of applications, particularly in small animal model research. Some smaller versions of imaging methods improve the techniques ' efficacy. These often decrease the number of animals required for a specific study.      

Preclinical In-vivo Imaging Market Analysis - By Reagent                 

  • Optical imaging reagents   
    • Bioluminescent reagents
    • Fluorescent imaging reagents
  • Nuclear imaging reagents 
    • Preclinical PET tracers
    • Preclinical SPECT probes
  • MRI contrast agents            
  • Ultrasound contrast agents             
  • CT contrast agents              

On the basis of reagent, the Ultrasound Contrast agents segment is anticipated to dominate the global market owing to their increased application in multiple imaging methods. 

Regional Analysis:

Regionally, North America holds the largest share of the global preclinical imaging market, followed by Europe. North America dominates the global market given the rapid adoption by end-users of several types of modalities, technological advancement, increased prevalence of chronic diseases like cancer, cardiovascular disease, and many others.

Factors including rising R&D activities by big pharma and biotech companies in developing nations and increased government funding for the development of the pharmaceutical industry are stimulating the growth of the preclinical imaging market in the Asia-Pacific region.,

Key industry participants profiled in this report are

  • Aspect Imaging
  • Biospace Lab S.A.
  • Bruker Corporation
  • LI-COR Biosciences
  • Mediso Ltd.
  • MILabs B.V.
  • MR Solutions Ltd
  • PerkinElmer, Inc.
  • TriFoil Imaging
  • FUJIFILM VisualSonics, Inc.

This report comes with:

  • Current and future Preclinical In-vivo Imaging Market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in excel)

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Rest of Latin America          

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic,economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the environmental factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development micro
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Preclinical in-vivo imaging Market By Region, From 2019 - 2024 (USD Million)
  2. Global Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  3. Global Preclinical Optical imaging Market By Region, From 2019 - 2024 (USD Million)
  4. Global Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  5. Global Preclinical Standalone fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  6. Global Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2019 - 2024 (USD Million)
  7. Global Preclinical Nuclear imaging Market By Region, From 2019 - 2024 (USD Million)
  8. Global Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2019 - 2024 (USD Million)
  9. Global Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2019 - 2024 (USD Million)
  10. Global Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2019 - 2024 (USD Million)
  11. Global Preclinical Micro-MRI Market By Region, From 2019 - 2024 (USD Million)
  12. Global Preclinical Micro-CT Market By Region, From 2019 - 2024 (USD Million)
  13. Global Preclinical Micro-ultrasound Market By Region, From 2019 - 2024 (USD Million)
  14. Global Preclinical Photoacoustic Market By Region, From 2019 - 2024 (USD Million)
  15. Global Preclinical Magnetic particle imaging systems Market By Region, From 2019 - 2024 (USD Million)
  16. Global Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  17. Global Preclinical Optical imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  18. Global Preclinical Bioluminescent reagents Market By Region, From 2019 - 2024 (USD Million)
  19. Global Preclinical Fluorescent imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  20. Global Preclinical Nuclear imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  21. Global Preclinical PET tracers Market By Region, From 2019 - 2024 (USD Million)
  22. Global Preclinical SPECT probes Market By Region, From 2019 - 2024 (USD Million)
  23. Global Preclinical MRI contrast agents Market By Region, From 2019 - 2024 (USD Million)
  24. Global Preclinical Ultrasound contrast agents Market By Region, From 2019 - 2024 (USD Million)
  25. Global Preclinical CT contrast agents Market By Region, From 2019 - 2024 (USD Million)
  26. North America Preclinical in-vivo imaging Market By Region, From 2019 - 2024 (USD Million)
  27. North America Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  28. North America Preclinical Optical imaging Market By Region, From 2019 - 2024 (USD Million)
  29. North America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  30. North America Preclinical Standalone fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  31. North America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2019 - 2024 (USD Million)
  32. North America Preclinical Nuclear imaging Market By Region, From 2019 - 2024 (USD Million)
  33. North America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2019 - 2024 (USD Million)
  34. North America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2019 - 2024 (USD Million)
  35. North America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2019 - 2024 (USD Million)
  36. North America Preclinical Micro-MRI Market By Region, From 2019 - 2024 (USD Million)
  37. North America Preclinical Micro-CT Market By Region, From 2019 - 2024 (USD Million)
  38. North America Preclinical Micro-ultrasound Market By Region, From 2019 - 2024 (USD Million)
  39. North America Preclinical Photoacoustic Market By Region, From 2019 - 2024 (USD Million)
  40. North America Preclinical Magnetic particle imaging systems Market By Region, From 2019 - 2024 (USD Million)
  41. North America Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  42. North America Preclinical Optical imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  43. North America Preclinical Bioluminescent reagents Market By Region, From 2019 - 2024 (USD Million)
  44. North America Preclinical Fluorescent imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  45. North America Preclinical Nuclear imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  46. North America Preclinical PET tracers Market By Region, From 2019 - 2024 (USD Million)
  47. North America Preclinical SPECT probes Market By Region, From 2019 - 2024 (USD Million)
  48. North America Preclinical MRI contrast agents Market By Region, From 2019 - 2024 (USD Million)
  49. North America Preclinical Ultrasound contrast agents Market By Region, From 2019 - 2024 (USD Million)
  50. North America Preclinical CT contrast agents Market By Region, From 2019 - 2024 (USD Million)
  51. United States Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  52. United States Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  53. United States Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  54. United States Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  55. United States Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  56. United States Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  57. Canada Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  58. Canada Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  59. Canada Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  60. Canada Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  61. Canada Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  62. Canada Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  63. Europe Preclinical in-vivo imaging Market By Region, From 2019 - 2024 (USD Million)
  64. Europe Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  65. Europe Preclinical Optical imaging Market By Region, From 2019 - 2024 (USD Million)
  66. Europe Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  67. Europe Preclinical Standalone fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  68. Europe Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2019 - 2024 (USD Million)
  69. Europe Preclinical Nuclear imaging Market By Region, From 2019 - 2024 (USD Million)
  70. Europe Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2019 - 2024 (USD Million)
  71. Europe Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2019 - 2024 (USD Million)
  72. Europe Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2019 - 2024 (USD Million)
  73. Europe Preclinical Micro-MRI Market By Region, From 2019 - 2024 (USD Million)
  74. Europe Preclinical Micro-CT Market By Region, From 2019 - 2024 (USD Million)
  75. Europe Preclinical Micro-ultrasound Market By Region, From 2019 - 2024 (USD Million)
  76. Europe Preclinical Photoacoustic Market By Region, From 2019 - 2024 (USD Million)
  77. Europe Preclinical Magnetic particle imaging systems Market By Region, From 2019 - 2024 (USD Million)
  78. Europe Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  79. Europe Preclinical Optical imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  80. Europe Preclinical Bioluminescent reagents Market By Region, From 2019 - 2024 (USD Million)
  81. Europe Preclinical Fluorescent imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  82. Europe Preclinical Nuclear imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  83. Europe Preclinical PET tracers Market By Region, From 2019 - 2024 (USD Million)
  84. Europe Preclinical SPECT probes Market By Region, From 2019 - 2024 (USD Million)
  85. Europe Preclinical MRI contrast agents Market By Region, From 2019 - 2024 (USD Million)
  86. Europe Preclinical Ultrasound contrast agents Market By Region, From 2019 - 2024 (USD Million)
  87. Europe Preclinical CT contrast agents Market By Region, From 2019 - 2024 (USD Million)
  88. U.K Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  89. U.K Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  90. U.K Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  91. U.K Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  92. U.K Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  93. U.K Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  94. Spain Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  95. Spain Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  96. Spain Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  97. Spain Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  98. Spain Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  99. Spain Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  100. Germany Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  101. Germany Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  102. Germany Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  103. Germany Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  104. Germany Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  105. Germany Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  106. Italy Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  107. Italy Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  108. Italy Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  109. Italy Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  110. Italy Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  111. Italy Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  112. France Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  113. France Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  114. France Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  115. France Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  116. France Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  117. France Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  118. Asia-Pacific Preclinical in-vivo imaging Market By Region, From 2019 - 2024 (USD Million)
  119. Asia-Pacific Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  120. Asia-Pacific Preclinical Optical imaging Market By Region, From 2019 - 2024 (USD Million)
  121. Asia-Pacific Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  122. Asia-Pacific Preclinical Standalone fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  123. Asia-Pacific Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2019 - 2024 (USD Million)
  124. Asia-Pacific Preclinical Nuclear imaging Market By Region, From 2019 - 2024 (USD Million)
  125. Asia-Pacific Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2019 - 2024 (USD Million)
  126. Asia-Pacific Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2019 - 2024 (USD Million)
  127. Asia-Pacific Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2019 - 2024 (USD Million)
  128. Asia-Pacific Preclinical Micro-MRI Market By Region, From 2019 - 2024 (USD Million)
  129. Asia-Pacific Preclinical Micro-CT Market By Region, From 2019 - 2024 (USD Million)
  130. Asia-Pacific Preclinical Micro-ultrasound Market By Region, From 2019 - 2024 (USD Million)
  131. Asia-Pacific Preclinical Photoacoustic Market By Region, From 2019 - 2024 (USD Million)
  132. Asia-Pacific Preclinical Magnetic particle imaging systems Market By Region, From 2019 - 2024 (USD Million)
  133. Asia-Pacific Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  134. Asia-Pacific Preclinical Optical imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  135. Asia-Pacific Preclinical Bioluminescent reagents Market By Region, From 2019 - 2024 (USD Million)
  136. Asia-Pacific Preclinical Fluorescent imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  137. Asia-Pacific Preclinical Nuclear imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  138. Asia-Pacific Preclinical PET tracers Market By Region, From 2019 - 2024 (USD Million)
  139. Asia-Pacific Preclinical SPECT probes Market By Region, From 2019 - 2024 (USD Million)
  140. Asia-Pacific Preclinical MRI contrast agents Market By Region, From 2019 - 2024 (USD Million)
  141. Asia-Pacific Preclinical Ultrasound contrast agents Market By Region, From 2019 - 2024 (USD Million)
  142. Asia-Pacific Preclinical CT contrast agents Market By Region, From 2019 - 2024 (USD Million)
  143. China Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  144. China Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  145. China Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  146. China Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  147. China Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  148. China Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  149. India Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  150. India Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  151. India Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  152. India Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  153. India Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  154. India Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  155. Japan Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  156. Japan Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  157. Japan Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  158. Japan Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  159. Japan Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  160. Japan Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  161. South Korea Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  162. South Korea Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  163. South Korea Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  164. South Korea Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  165. South Korea Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  166. South Korea Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  167. Australia Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  168. Australia Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  169. Australia Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  170. Australia Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  171. Australia Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  172. Australia Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  173. Latin America Preclinical in-vivo imaging Market By Region, From 2019 - 2024 (USD Million)
  174. Latin America Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  175. Latin America Preclinical Optical imaging Market By Region, From 2019 - 2024 (USD Million)
  176. Latin America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  177. Latin America Preclinical Standalone fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  178. Latin America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2019 - 2024 (USD Million)
  179. Latin America Preclinical Nuclear imaging Market By Region, From 2019 - 2024 (USD Million)
  180. Latin America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2019 - 2024 (USD Million)
  181. Latin America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2019 - 2024 (USD Million)
  182. Latin America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2019 - 2024 (USD Million)
  183. Latin America Preclinical Micro-MRI Market By Region, From 2019 - 2024 (USD Million)
  184. Latin America Preclinical Micro-CT Market By Region, From 2019 - 2024 (USD Million)
  185. Latin America Preclinical Micro-ultrasound Market By Region, From 2019 - 2024 (USD Million)
  186. Latin America Preclinical Photoacoustic Market By Region, From 2019 - 2024 (USD Million)
  187. Latin America Preclinical Magnetic particle imaging systems Market By Region, From 2019 - 2024 (USD Million)
  188. Latin America Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  189. Latin America Preclinical Optical imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  190. Latin America Preclinical Bioluminescent reagents Market By Region, From 2019 - 2024 (USD Million)
  191. Latin America Preclinical Fluorescent imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  192. Latin America Preclinical Nuclear imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  193. Latin America Preclinical PET tracers Market By Region, From 2019 - 2024 (USD Million)
  194. Latin America Preclinical SPECT probes Market By Region, From 2019 - 2024 (USD Million)
  195. Latin America Preclinical MRI contrast agents Market By Region, From 2019 - 2024 (USD Million)
  196. Latin America Preclinical Ultrasound contrast agents Market By Region, From 2019 - 2024 (USD Million)
  197. Latin America Preclinical CT contrast agents Market By Region, From 2019 - 2024 (USD Million)
  198. Brazil Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  199. Brazil Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  200. Brazil Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  201. Brazil Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  202. Brazil Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  203. Brazil Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  204. Argentina Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  205. Argentina Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  206. Argentina Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  207. Argentina Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  208. Argentina Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  209. Argentina Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  210. Mexico Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  211. Mexico Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  212. Mexico Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  213. Mexico Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  214. Mexico Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  215. Mexico Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  216. Middle East & Africa Preclinical in-vivo imaging Market By Region, From 2019 - 2024 (USD Million)
  217. Middle East & Africa Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  218. Middle East & Africa Preclinical Optical imaging Market By Region, From 2019 - 2024 (USD Million)
  219. Middle East & Africa Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  220. Middle East & Africa Preclinical Standalone fluorescence imaging systems Market By Region, From 2019 - 2024 (USD Million)
  221. Middle East & Africa Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2019 - 2024 (USD Million)
  222. Middle East & Africa Preclinical Nuclear imaging Market By Region, From 2019 - 2024 (USD Million)
  223. Middle East & Africa Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2019 - 2024 (USD Million)
  224. Middle East & Africa Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2019 - 2024 (USD Million)
  225. Middle East & Africa Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2019 - 2024 (USD Million)
  226. Middle East & Africa Preclinical Micro-MRI Market By Region, From 2019 - 2024 (USD Million)
  227. Middle East & Africa Preclinical Micro-CT Market By Region, From 2019 - 2024 (USD Million)
  228. Middle East & Africa Preclinical Micro-ultrasound Market By Region, From 2019 - 2024 (USD Million)
  229. Middle East & Africa Preclinical Photoacoustic Market By Region, From 2019 - 2024 (USD Million)
  230. Middle East & Africa Preclinical Magnetic particle imaging systems Market By Region, From 2019 - 2024 (USD Million)
  231. Middle East & Africa Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  232. Middle East & Africa Preclinical Optical imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  233. Middle East & Africa Preclinical Bioluminescent reagents Market By Region, From 2019 - 2024 (USD Million)
  234. Middle East & Africa Preclinical Fluorescent imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  235. Middle East & Africa Preclinical Nuclear imaging reagents Market By Region, From 2019 - 2024 (USD Million)
  236. Middle East & Africa Preclinical PET tracers Market By Region, From 2019 - 2024 (USD Million)
  237. Middle East & Africa Preclinical SPECT probes Market By Region, From 2019 - 2024 (USD Million)
  238. Middle East & Africa Preclinical MRI contrast agents Market By Region, From 2019 - 2024 (USD Million)
  239. Middle East & Africa Preclinical Ultrasound contrast agents Market By Region, From 2019 - 2024 (USD Million)
  240. Middle East & Africa Preclinical CT contrast agents Market By Region, From 2019 - 2024 (USD Million)
  241. Middle East Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  242. Middle East Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  243. Middle East Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  244. Middle East Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  245. Middle East Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  246. Middle East Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)
  247. Africa Preclinical in-vivo imaging Market By Modality, From 2019 - 2024 (USD Million)
  248. Africa Preclinical Optical Imaging Market By Optical imaging, From 2019 - 2024 (USD Million)
  249. Africa Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2019 - 2024 (USD Million)
  250. Africa Preclinical in-vivo imaging Market By Reagent, From 2019 - 2024 (USD Million)
  251. Africa Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2019 - 2024 (USD Million)
  252. Africa Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2019 - 2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample